Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Blood virosphere in febrile Tanzanian children.

Tytuł:
Blood virosphere in febrile Tanzanian children.
Autorzy:
Cordey S; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.; Laboratory of Virology, Division of Infectious Diseases and Division of Laboratory Medicine, University Hospitals of Geneva & Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Laubscher F; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.; Laboratory of Virology, Division of Infectious Diseases and Division of Laboratory Medicine, University Hospitals of Geneva & Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Hartley MA; Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.; Intelligent Global Health, Machine Learning and Optimization Laboratory, EPFL, Lausanne, Switzerland.
Junier T; Global Health Institute, School of Life Sciences, EPFL, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Keitel K; Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.; Department of Paediatric Emergency Medicine, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Docquier M; iGE3 Genomics Platform, University of Geneva, Geneva, Switzerland.; Department of Genetics and Evolution, University of Geneva, Geneva, Switzerland.
Guex N; Bioinformatics Competence Center, University of Lausanne and EPFL, Lausanne, Switzerland.
Iseli C; Bioinformatics Competence Center, University of Lausanne and EPFL, Lausanne, Switzerland.
Vieille G; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.; Laboratory of Virology, Division of Infectious Diseases and Division of Laboratory Medicine, University Hospitals of Geneva & Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Le Mercier P; SwissProt group, SIB Swiss Institute of Bioinformatics, Geneva, Switzerland.
Gleizes A; SwissProt group, SIB Swiss Institute of Bioinformatics, Geneva, Switzerland.
Samaka J; Ifakara Health Institute, Dar es Salaam, Tanzania.
Mlaganile T; Ifakara Health Institute, Dar es Salaam, Tanzania.
Kagoro F; Ifakara Health Institute, Dar es Salaam, Tanzania.
Masimba J; Ifakara Health Institute, Dar es Salaam, Tanzania.
Said Z; Ifakara Health Institute, Dar es Salaam, Tanzania.
Temba H; Ifakara Health Institute, Dar es Salaam, Tanzania.
Elbanna GH; Intelligent Global Health, Machine Learning and Optimization Laboratory, EPFL, Lausanne, Switzerland.
Tapparel C; Department of Microbiology and Molecular Medicine, University of Geneva Medical School, Geneva, Switzerland.
Zanella MC; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.; Laboratory of Virology, Division of Infectious Diseases and Division of Laboratory Medicine, University Hospitals of Geneva & Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Xenarios I; Health2030 Genome Center, Geneva, Switzerland.; Agora Center, University of Lausanne, Lausanne, Switzerland.
Fellay J; Global Health Institute, School of Life Sciences, EPFL, Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Precision Medicine Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
D'Acremont V; Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.; Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.
Kaiser L; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.; Laboratory of Virology, Division of Infectious Diseases and Division of Laboratory Medicine, University Hospitals of Geneva & Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.
Źródło:
Emerging microbes & infections [Emerg Microbes Infect] 2021 Dec; Vol. 10 (1), pp. 982-993.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: 2019- : [Philadelphia, PA] : Taylor & Francis
Original Publication: New York : NPG, 2012-2018.
MeSH Terms:
Fever/*virology
Metagenomics/*methods
Virus Diseases/*blood
Viruses/*classification
Child, Preschool ; High-Throughput Nucleotide Sequencing ; Humans ; Infant ; Infant, Newborn ; Retrospective Studies ; Sequence Analysis, DNA ; Sequence Analysis, RNA ; Tanzania ; Virus Diseases/virology ; Viruses/genetics ; Viruses/isolation & purification
References:
PLoS One. 2012;7(6):e27735. (PMID: 22719819)
Blood Transfus. 2016 Sep;14(5):400-7. (PMID: 27136432)
PLoS One. 2012;7(11):e50937. (PMID: 23226428)
Nat Rev Microbiol. 2013 Feb;11(2):133-41. (PMID: 23268232)
J Gen Virol. 2016 Dec;97(12):3359-3367. (PMID: 27902331)
J Clin Microbiol. 2008 Feb;46(2):507-14. (PMID: 18094127)
Bioinformatics. 2012 Jun 1;28(11):1420-8. (PMID: 22495754)
Arch Virol. 2015 Apr;160(4):893-908. (PMID: 25680568)
Annu Rev Virol. 2019 Sep 29;6(1):119-139. (PMID: 31100994)
Clin Infect Dis. 2019 Aug 30;69(6):987-994. (PMID: 30508036)
PLoS Med. 2007 Apr;4(4):e121. (PMID: 17439294)
BMC Bioinformatics. 2009 Dec 15;10:421. (PMID: 20003500)
Clin Microbiol Infect. 2018 Aug;24(8):808-814. (PMID: 29454844)
Transfusion. 2019 Oct;59(10):3177-3185. (PMID: 31393615)
Viruses. 2020 Nov 01;12(11):. (PMID: 33139591)
Viruses. 2019 Jun 27;11(7):. (PMID: 31252663)
Transfusion. 2016 Sep;56(9):2248-55. (PMID: 27306718)
PLoS Pathog. 2017 Mar 22;13(3):e1006292. (PMID: 28328962)
Genes (Basel). 2019 Aug 28;10(9):. (PMID: 31466373)
Emerg Infect Dis. 2018 Feb;24(2):267-274. (PMID: 29350142)
Front Microbiol. 2015 Mar 24;6:185. (PMID: 25852655)
Cell. 2013 Nov 21;155(5):1178-87. (PMID: 24267896)
Emerg Microbes Infect. 2017 Sep 20;6(9):e84. (PMID: 28928418)
J Med Virol. 2008 Dec;80(12):2169-76. (PMID: 19040295)
J Clin Microbiol. 2007 Jul;45(7):2144-50. (PMID: 17460053)
Virology. 2018 Oct;523:74-88. (PMID: 30098450)
Curr Opin Virol. 2012 Jun;2(3):344-52. (PMID: 22463981)
Clin Microbiol Rev. 2020 Aug 26;33(4):. (PMID: 32847820)
PLoS One. 2019 Jun 20;14(6):e0218318. (PMID: 31220115)
PLoS One. 2020 Mar 5;15(3):e0229993. (PMID: 32134963)
Clin Microbiol Infect. 2019 Oct;25(10):1277-1285. (PMID: 31059795)
Emerg Health Threats J. 2013 Sep 10;6:19780. (PMID: 24119538)
mSphere. 2018 Aug 22;3(4):. (PMID: 30135221)
PLoS Med. 2017 Oct 23;14(10):e1002411. (PMID: 29059253)
Transfusion. 2017 Jul;57(7):1787-1800. (PMID: 28497550)
Rev Med Virol. 2017 Jan;27(1):. (PMID: 27723176)
J Med Virol. 2016 Feb;88(2):356-60. (PMID: 26212039)
Rev Med Virol. 2010 Nov;20(6):392-407. (PMID: 20925048)
mBio. 2013 Sep 03;4(5):e00598-13. (PMID: 24003179)
Annu Rev Microbiol. 2016 Sep 8;70:125-41. (PMID: 27607550)
Microbiol Resour Announc. 2019 Aug 29;8(35):. (PMID: 31467101)
J Clin Microbiol. 2014 Sep;52(9):3351-61. (PMID: 25009045)
Curr Top Microbiol Immunol. 2009;331:21-33. (PMID: 19230555)
Emerg Microbes Infect. 2019;8(1):613-623. (PMID: 30999808)
Emerg Microbes Infect. 2020 Dec;9(1):1242-1244. (PMID: 32524907)
J Virol. 2013 Oct;87(19):10912-5. (PMID: 23903845)
Sci Rep. 2019 Feb 20;9(1):2360. (PMID: 30787417)
Genome Announc. 2014 Mar 27;2(2):. (PMID: 24675858)
Clin Microbiol Infect. 2019 Feb;25(2):225-232. (PMID: 29787887)
Contributed Indexing:
Keywords: Blood virome; children; fever; metagenomic next-generation sequencing; virosphere
Molecular Sequence:
ClinicalTrials.gov NCT02225769
Entry Date(s):
Date Created: 20210430 Date Completed: 20211101 Latest Revision: 20211101
Update Code:
20240105
PubMed Central ID:
PMC8171259
DOI:
10.1080/22221751.2021.1925161
PMID:
33929935
Czasopismo naukowe
Viral infections are the leading cause of childhood acute febrile illnesses motivating consultation in sub-Saharan Africa. The majority of causal viruses are never identified in low-resource clinical settings as such testing is either not part of routine screening or available diagnostic tools have limited ability to detect new/unexpected viral variants. An in-depth exploration of the blood virome is therefore necessary to clarify the potential viral origin of fever in children. Metagenomic next-generation sequencing is a powerful tool for such broad investigations, allowing the detection of RNA and DNA viral genomes. Here, we describe the blood virome of 816 febrile children (<5 years) presenting at outpatient departments in Dar es Salaam over one-year. We show that half of the patients (394/816) had at least one detected virus recognized as causes of human infection/disease (13.8% enteroviruses (enterovirus A, B, C, and rhinovirus A and C), 12% rotaviruses, 11% human herpesvirus type 6). Additionally, we report the detection of a large number of viruses (related to arthropod, vertebrate or mammalian viral species) not yet known to cause human infection/disease, highlighting those who should be on the radar, deserve specific attention in the febrile paediatric population and, more broadly, for surveillance of emerging pathogens. Trial registration: ClinicalTrials.gov identifier: NCT02225769.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies